Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Non-Alkaloid Cholinesterase Inhibitory Compounds
The classes of cholinesterase inhibitors discussed here are mainly terpenoids, phenolic compounds, and coumarins, and some of these compounds have shown high potency. In order to consider which classes are most suitable, based on the benefits and drawbacks, certain structural features of each class will be of great importance. Using chalcones as an example, it is believed that besides economical and cost-effective production, small molecular size and flexibility for modifications to improve lipophilicity necessary for blood-brain barrier permeability are important to consider for a preferred potential therapeutic candidate for AD.
  • 606
  • 29 Sep 2021
Topic Review
Asthma and Obesity
Asthma is a common chronic airway disease characterized by variable airflow limitation resulting from the combination of airway narrowing, airway hypersensitivity, airway wall thickening, and increased mucus hypersecretion. Airway narrowing results from both chronic inflammation and airway remodeling. Asthma is a heterogeneous disease with several distinct clinical presentations (phenotypes) and complex pathophysiological mechanisms (endotypes). Obesity is the consequence of an excessive body fat accumulation due to an imbalance of energy intake and energy expenditure. Diagnosis of obesity is usually established by assessing the body mass index (BMI) ≥ 30 kg/m2.
  • 605
  • 22 Feb 2021
Topic Review
Megalin
Megalin, a recently discovered endocytic receptor for prorenin and renin, not only contributes to renin/prorenin reabsorption in the proximal tubule of the kidney, but simultaneously plays a role in renal Ang II generation, although how exactly this occurs is still unknown . 
  • 604
  • 11 Nov 2021
Topic Review
Subcellular Localization of Membrane-Type-1 Matrix Metalloproteinase
Matrix metalloproteinases (MMPs) are critical enzymes involved in a variety of cellular processes. MMPs are well known for their ability to degrade the extracellular matrix (ECM) and their extracellular role in cell migration. Membrane-type-1 matrix metalloproteinase (MT1-MMP), a transmembrane protein, is first known to localize to the cell membrane.
  • 604
  • 15 Sep 2022
Topic Review
Anti-inflammatory Effect of Essential Oil from Z. striolatum
Zingiber striolatum Diels (Z. striolatum), a widely popular vegetable in China, is famous for its medicinal and nutritional values. However, the anti-inflammatory effects of essential oil from Z. striolatum (EOZS) remain unclear. This research unveils the antioxidant capability and potential molecular mechanism of EOZS in regulating inflammatory response, and suggests the application of EOZS as a natural antioxidant and anti-inflammatory agent in the pharmaceutical and functional food industries. 
  • 603
  • 06 Jan 2022
Topic Review
Pharmacogenetics in Chronic Kidney Disease
Chronic kidney disease (CKD) is an important global public health problem due to its high prevalence and morbidity. Although the treatment of nephrology patients has changed considerably, ineffectiveness and side effects of medications represent a major issue. Pharmacogenetics could fill this gap.
  • 602
  • 28 Jul 2021
Topic Review
Mood Stabilizers of  First and Second Generation
Mood stabilizers can be classified into two generations based on the chronology of their introduction into the psychiatric armamentarium. First-generation mood stabilizers (FGMS) such as lithium, valproates and carbamazepine were introduced in the years 1960-1970s. Second-generation mood stabilizers (SGMS) started in 1995, with a discovery of the mood-stabilizing properties of clozapine. The SGMS include atypical antipsychotics such as clozapine, olanzapine, quetiapine, aripiprazole, and risperidone as well as a new anticonvulsant drug, lamotrigine. Recently as a candidate for SGMS, a novel antipsychotic, lurasidone, has been suggested. Several other atypical antipsychotics and anticonvulsants, as well as memantine showed some usefulness in the treatment and prophylaxis of bipolar disorder; however, they have not fully met the author’s criteria for mood stabilizers. 
  • 601
  • 19 May 2023
Topic Review
Clopidogrel Resistance (CR)
Clopidogrel is a widely-used antiplatelet drug. It is important for the treatment and prevention of coronary heart disease. Clopidogrel can effectively reduce platelet activity and therefore reduce stent thrombosis. However, some patients still have ischemic events despite taking the clopidogrel due to the alteration in clopidogrel metabolism attributable to various genetic and non-genetic factors. This review aims to summarise the mechanisms and causes of clopidogrel resistance (CR) and potential strategies to overcome it. 
  • 599
  • 07 May 2021
Topic Review
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in Lung Cancer
Lung cancer is a common malignancy worldwide, with high morbidity and mortality. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor that not only regulates different hallmarks of cancer, such as tumorigenesis, cell proliferation, and metastasis but also regulates the occurrence and maintenance of cancer stem cells (CSCs). Abnormal STAT3 activity has been found in a variety of cancers, including lung cancer, and its phosphorylation level is associated with a poor prognosis of lung cancer. Therefore, the STAT3 pathway may represent a promising therapeutic target for the treatment of lung cancer. Various types of STAT3 inhibitors, including natural compounds, small molecules, and gene-based therapies, have been developed through direct and indirect strategies, although most of them are still in the preclinical or early clinical stages.
  • 599
  • 23 Dec 2022
Topic Review
Environmental Pollution's Impact on cancer
Nowadays, cancer is the leading cause of death in humans before they reach old age , and some specific, once rare, types connected to environmental and occupational contamination are increasing (e.g., testicular cancer , thyroid cancer , non-Hodgkin’s lymphoma , leukaemia , etc.). After about three decades of research from the first evidence of a link between environmental pollution and cancer in the 1980s, it is easy to feel that we are all, directly or indirectly, subject to an uncontrolled experiment. This makes human studies difficult because humanity may, at this point, lack unexposed controls, such as human beings who have never been in contact with environmental pollution.
  • 596
  • 07 Jun 2021
Topic Review
New Therapeutic Approaches in Treatment of Dyslipidaemia
Dyslipidaemia is a well-known risk factor for the development of cardiovascular disease. Traditional statin therapy remains the cornerstone therapeutic approach. Ezetimibe showed good but limited results when used in combination with statins. Bempedoic acid has been thoroughly studied in multiple clinical trials, with a reduction in LDL cholesterol by approximately 15%. The first approved monoclonal antibodies for the treatment of dyslipidaemia, PCSK9 inhibitors, are currently used as second-line treatment for patients with unregulated lipid levels on statin or statin combination therapy. A new siRNA molecule, inclisiran, demonstrates great potential, particularly concerning compliance, as it is administered twice yearly and pelacarsen, an antisense oligonucleotide that targets lipoprotein(a) and lowers its levels. Volanesorsen is the first drug that was designed to target chylomicrons and lower triglyceride levels, and olezarsen, the next in-line chylomicron lowering agent, is currently being researched. The newest possibilities for the treatment of dyslipidaemia are ANGPTL3 inhibitors with evinacumab, already approved by the FDA, and EMA for the treatment of familial hypercholesterolemia. 
  • 596
  • 12 Aug 2022
Topic Review
The Genus Cetraria s. str.
The genus Cetraria s. str. (Parmeliaceae family, Cetrarioid clade) consists of 15 species of mostly erect brown or greenish yellow fruticose or subfoliose thallus. These Cetraria species have a cosmopolitan distribution, being primarily located in the Northern Hemisphere, in North America and in the Eurasia area. 
  • 595
  • 24 Aug 2022
Topic Review
Ivabradine Effects on Cardiac Function
Cardiac remodeling can cause ventricular dysfunction and progress to heart failure, a cardiovascular disease that claims many lives globally. Ivabradine, a funny channel (If) inhibitor, is used in patients with chronic heart failure as an adjunct to other heart failure medications.
  • 594
  • 10 Feb 2023
Topic Review
Mechanisms of Light-Triggered Drug Release from Liposomes
Light-triggered mechanisms that can be exploited to release encapsulated drugs from liposomes are photoisomerization, photocleavage (photo-oxidation), surface plasmon resonance absorption (photothermal activation), photochemical hydrophobicity change (photochemical activation), and photo-crosslinking and de-crosslinking.
  • 594
  • 18 Feb 2024
Topic Review
Aromatic Plants Metabolic Engineering
Secondary metabolites of aromatic plants are used in many health applications as drugs, pheromones, insecticides, fragrances, and antioxidants. Due to the huge commercial demand for these secondary metabolites, the need to overcome the insufficient productivity of aromatic plants has become a significant challenge. Plant breeding is a traditional, labor-intensive, and limited method to improve the ability of aromatic plants to produce secondary metabolites.
  • 593
  • 23 Dec 2022
Topic Review
Therapeutic Sequencing in ALK+ NSCLC
Anaplastic lymphoma kinase-rearranged non-small-cell lung cancer (ALK+ NSCLC) is a model disease for the use of targeted pharmaceuticals in thoracic oncology. This entry summarizes the state-of-the-art treatment for these tumors as of January 2021, with a special emphasis in the sequential use of various compounds as well as the growing importance of molecular profiling and monitoring for patient management.
  • 592
  • 20 Apr 2021
Topic Review
Epigallocatechin 3-Gallate and Myricetin against SARS-CoV-2 Infection
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the deadliest virus since the 1918 influenza virus, has posed a serious threat to global health security. Tremendous research efforts have been undertaken, aiming at controlling and/or treating SARS-CoV-2 infection. The exploration of non-toxic and cost-effective dietary components, such as epigallocatechin 3-gallate and myricetin, for health improvement and disease treatment has recently attracted substantial research attention.
  • 592
  • 07 Aug 2023
Topic Review
Ginkgo biloba and Phenolic Compounds in Age-Related Diseases
Ginkgo biloba, and its main constituent compounds, the ginkgolides, have become something of a celebrity as far as natural drug candidates go.
  • 591
  • 28 Jan 2023
Topic Review
Novel Psychoactive Substances
Novel psychoactive substances (NPS) represent a severe health risk for drug users. The molecular mechanisms underlying the action of NPS are more complex than expected, with a wide range of overlap among activated receptors and neurotransmitter systems.
  • 590
  • 21 May 2021
Topic Review
Approaches to Identify Functional SNPs in mRNA 3′UTRs
The complementary interaction of microRNAs (miRNAs) with their binding sites in the 3′untranslated regions (3′UTRs) of target gene mRNAs represses translation, playing a leading role in gene expression control. MiRNA recognition elements (MREs) in the 3′UTRs of genes often contain single nucleotide polymorphisms (SNPs), which can change the binding affinity for target miRNAs leading to dysregulated gene expression. Accumulated data suggest that these SNPs can be associated with various human pathologies (cancer, diabetes, neuropsychiatric disorders, and cardiovascular diseases) by disturbing the interaction of miRNAs with their MREs located in mRNA 3′UTRs. Numerous data show the role of SNPs in 3′UTR MREs in individual drug susceptibility and drug resistance mechanisms. This work brief the data on such SNPs focusing on the most rigorously proven cases. Some SNPs belong to conventional genes from the drug-metabolizing system (in particular, the genes coding for cytochromes P450 (CYP 450), phase II enzymes (SULT1A1 and UGT1A), and ABCB3 transporter and their expression regulators (PXR and GATA4)). Other examples of SNPs are related to the genes involved in DNA repair, RNA editing, and specific drug metabolisms. The gene-by-gene studies and genome-wide approaches utilized or potentially utilizable to detect the MRE SNPs associated with individual response to drugs discussed.
  • 590
  • 24 Nov 2022
  • Page
  • of
  • 53
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
ScholarVision Creations
Feedback